We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




VisualDx AI App for iPhone Improves Disease Diagnosis

By HospiMedica International staff writers
Posted on 12 Oct 2017
VisualDx (Rochester, NY, USA) has enhanced its VisualDx app with Core ML, a new framework enabling on-device machine learning to help provide healthcare professionals with quick and accurate identification of rashes and skin lesions. More...
The technology will further help non-dermatology practitioners in identifying and treating a variety of skin conditions which were previously difficult to diagnose without a specialist referral.

The full VisualDx suite is a web- and app-based clinical decision support system designed to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient safety. It combines clinical search with a database of more than 41,000 of the best medical images in the world, plus medical knowledge from experts to help with diagnosis, treatment, self-education, and patient communication.

The VisualDx app helps emergency medicine, urgent care and primary care professionals make smarter, faster, more accurate diagnoses and treatment choices based on a series of questions, including global locations, and interfaces with information such as local/regional outbreaks and health and medication history. VisualDx + DermExpert, an addition to the VisualDx subscription, is available for iPhone and iPad on the App Store. The VisualDx technology analyzes photos taken by the clinician and classifies them within a second on an iPhone or iPad. The clinician views and confirms the lesion type classification, enters additional patient information and immediately reviews diagnostic possibilities and treatment options.

“iOS 11 with Core ML enables the type of on-device learning and artificial intelligence that will benefit patients, maintain their privacy, and allow for innovation in companies like ours,” said Art Papier MD, CEO and co-founder of VisualDx. “In a few milliseconds, our app makes a recommendation based on a photo of the condition, augmenting clinical thinking and driving better care.”

Related Links:
VisualDx


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Enteral Feeding Pump
Instilar 1420
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.